Olon is proud to present its Sustainability Manifesto 2021. The new Manifesto represents a transparent report of the commitment and results that the Group is pursuing globally, in each country it operates, and consistently with its strategy.
Olon has set very ambitious global targets of sustainability regarding waste and consumption of natural resources and energy as well. Based on the milestone set on the new Manifesto, the Group states its commitment to publishing sustainability on an annual basis.
Sustainability is an essential part of Olon's mission, which the company is pursuing with determination and perseverance, combined with an ambitious vision for the future: becoming a global leader in the production of APIs from an ethical and environmental perspective. Today the company embraces a new dimension of sustainability, that integrates respect for the environment, highly sustainable manufacturing approach as biotechnology, people, supply chain, social responsibility. Olon promotes and supports a new industrial model that sets far-sighted goals while never forgetting how precious people and natural resources are, which need to be protected. Playing the role of market leader also carries a social weight because it means performing a driving and motivational task.
Nice Insight, established in 2010, is the research division of That’s Nice, A Science Agency, providing data and analysis from proprietary annual surveys, custom primary qualitative and quantitative research as well as extensive secondary research. Current annual surveys include The Nice Insight Contract Development & Manufacturing (CDMO/CMO), Survey The Nice Insight Contract Research - Preclinical and Clinical (CRO) Survey, The Nice Insight Pharmaceutical Equipment Survey, and The Nice Insight Pharmaceutical Excipients Survey.
Olon is an Italian company world leader in the Active Pharmaceutical Ingredients (APIs) production, using synthetic and biological processes for Generic market as well as in Contract Development and Manufacturing (CDMO). Headquartered in Rodano (Italy), Olon has 11 manufacturing facilities – 8 located in Italy, 1 in Spain, 1 in USA and 1 in India, all compliant with international requirements, and 3 branch offices. Olon offers complete integrated packages and services to support the full development of APIs based on strong knowledge in both, Chemical and Biological processes, in a full cGMPs environment including a complete regulatory coverage.